Effectiveness of Stivarga (Regorafenib) for Patients With Metastatic Colorectal Cancer in the Hungarian Real World Setting
Phase of Trial: Phase IV
Latest Information Update: 23 May 2017
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 18 May 2017 Status changed from active, no longer recruiting to completed.
- 08 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 08 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.